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Abstract The current work presents results of experiments
on the calcium response evoked by the stimulation by
extracellular nucleotides occurring in control, nonstarved
glioma C6 cells and in cells after long-term (96 h) serum
starvation. Three nucleotide receptors were studied: P2Y1,
P2Y2 and P2Y12. Two of them, P2Y1 and P2Y2, directly
stimulate calcium response. The protein level of the P2Y2
receptor did not change during the serum starvation, while
P2Y1 protein level fell dramatically. Observed changes in
the calcium response generated by P2Y1 are directly
correlated with the receptor protein level as well as with
the amount of calcium present in the intracellular calcium
stores, partially depleted during starvation process. The
third receptor, P2Y12, did not directly evoke calcium
response, however it is activated by the same ligand as
P2Y1. The experiments with AR-C69941MX, the P2Y12-
specific antagonist, indicated that in control and serum-
starved cells, calcium response evoked by P2Y1 receptor is
potentiated by the activity of P2Y12-dependent signaling
pathways. This potentiation may be mediated by P2Y12
inhibitory effect on the plasma membrane calcium pump.
The calcium influx enhanced by the cooperation of P2Y1
and P2Y12 receptor activity directly depends on the
capacitative calcium entrance mechanism.
Key words AR-C69931MX.calciumsignalling.
capacitativecalciumentry.GliomaC6.nucleotide
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Introduction
In most cell types, a large number of cell functions are
regulated by the level of cytoplasmic Ca
2+. Efficient
calcium signalling requires a Ca
2+ source as well as
mechanisms for Ca
2+ depletion after a period of activation.
Studies on the Ca
2+ source have led to division of all cells
into two types, excitable and nonexcitable, based on the
presence of voltage-dependent calcium channels in their
plasma membranes [1, 2]. Transformed glial cells, such as
glioma C6, belong to the nonexcitable cells [3, 4]. We have
reported that an increase in KCl concentration in the
extracellular medium to 140 from 2.7 mM does not produce
any change in the intracellular Ca
2+ level in glioma C6 cells
[3]. On the contrary, under such conditions, excitable cells
open voltage-dependent Ca
2+ channels via membrane depo-
larization, and massive influx of Ca
2+ is observed [1, 2].
Nonexcitable cells are characterized by capacitative Ca
2+
entry, also known as store-operated Ca
2+ entry, regulated by
the concentration of calcium ions in the endoplasmic
reticulum (ER) pool [5–8]. The depletion of this pool (the
first phase of calcium response) causes the opening of
voltage-independent Ca
2+ channels in the plasma membrane
(PM), which permits the Ca
2+ entry (second phase of calcium
response). First messengers mediating inositol-1,4,5-trisphos-
phate (IP3) formation cause release of Ca
2+ from the ER via
IP3 receptors followed by Ca
2+ entry into the cell as a
consequence of the depletion of the ER store [5–8].
We have previously reported that, in glioma C6 cells,
stimulation of nucleotide receptors by agonists ATP, UTP,
ADP, or ADP-analogue 2-methylthioadenosine-5’-diphos-
phate (2MeSADP) initiates a biphasic Ca
2+ response
compatible with the typical capacitative model of Ca
2+
influx [9–12]. Among the large family of metabotropic P2Y
nucleotide receptors, P2Y2 responds to ATP and UTP,
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P2Y1 and P2Y2 receptors are both coupled to phospholi-
pase C (PLC) and are responsible for Ca
2+ mobilization
from intracellular stores, while the P2Y12 receptor is
negatively coupled to adenylate cyclase [13–17]. We have
also shown that differences in the cell culture conditions, i.e.
the presence or absence of serum in the cell culture medium,
have a strong effect on P2Y1 receptor mRNA expression,
which strongly decreases in the absence of serum [9, 10].
This effect is so strong that Slegers group [18], growing
glioma C6 cells in serum-free chemically-defined medium,
could not evoke P2Y1 receptor-dependent PI turnover and
suggested that, in these cells, the P2Y12 receptor was not
only coupled to inhibition of adenyl cyclase but also to
activation of PLC-independent Ca
2+ influx. According to
the authors, the mechanism of P2Y12-dependent calcium
influx remained to be determined, however, in Fig. 8 of
[19] and Fig. 1 of [20], they proposed the interesting idea
that stimulation of the P2Y12 receptor might generate, via
Gβγ subunits of Gi protein, a direct entry of extracellular
calcium [19, 20].
The aim of the present study was to check whether the
P2Y12 receptor may be directly responsible for the calcium
entry. Our results indicate a full correlation between the
P2Y1 receptor protein level and the extent of Ca
2+ response
in glioma C6 cells. Moreover, although Ca
2+ response
evoked by the P2Y1 receptor may be potentiated by P2Y12-
dependent signalling pathways, the hypothesis proposed by
other authors [18–20], that in this cell line P2Y12 is directly
responsible for Ca
2+ influx, seems to be doubtful. Thus,
data presented herein clarify the problem of the roles that
both receptors play in the calcium response.
Materials and methods
Materials
Dulbbeco’s Modified Eagle’s Medium (DMEM) and new-
born calf serum (NCS) were obtained from Gibco BRL.
ADP, 2MeSADP, UTP, EGTA, phosphate-buffered solutions
(PBS), penicillin and streptomycin were purchased from
Sigma Aldrich Chemical. Fura-2/AM was from Molecular
Probes. AR-C69931MX was a kind gift from AstraZeneca
(Wilmington, DE, USA). MRS 2179 tetraammonium salt
was from Tocris. Antibodies recognizing P2Y1, P2Y2, and
P2Y12 were purchased from Alomone and Sigma Aldrich
Chemical labs. Horseradish peroxidase-conjugated anti-
rabbit IgG was from Cell Signalling. Nitrocellulose
membrane and enhanced chemiluminescence detection
system (ECL) were from Amersham Pharmacia Biotech.
Medical X-ray films were from Foton Trading Poland. All
other reagents were purchased from Sigma Chemical.
Cell culture
Rat glioma C6 cells (passages 40–60) were obtained from
American Tissue Culture Collection and cultured in DMEM
with high glucose (4,500 g/dm
3) and GlutaMAX I,
supplemented with 10% (v/v) NCS, penicillin (100 UI/ml)
and streptomycin (50 μg/ml) under humidified atmosphere
of 5% CO2 at 37°C. For experiments, control cells were
cultivated in DMEM supplemented with 10% NCS to reach
90% confluence in 60-mm dishes (for Western blot
analysis) or on 22-mm glass coverslips in 35-mm dishes
(for calcium measurement). In case of serum-starved cells,
the medium was changed to DMEM without NCS 96 h
before the experiment.
Measurement of intracellular calcium
Thirty minutes before the calcium measurements, cells on
coverslips were washed once with PBS and once with
solution containing 137 mM NaCl, 2.7 mM KCl, 1 mM
Na2HPO4, 25 mM glucose, 20 mM HEPES (pH 7.4), 1 mM
MgCl2, 1% bovine serum albumin and 2 mM CaCl2
(standard buffer). In experiments performed in the absence
of external Ca
2+, 500 μM EGTA was added instead of
2 mM CaCl2. The cells were then incubated at 37°C for
30 min in the standard buffer with 2 μM Fura-2 AM.
Thereafter, the coverslips were mounted in a chamber on a
Nikon Diaphot inverted-stage microscope equipped with a
fluo ×40/1.3 NA oil-immersion objective lens. Fura-2
digital fluorescence microscopy was used to determine the
changes in intracellular calcium levels Ca2þ ½  i

[21].
Ludl Lep MAC 5000 filter wheel system loaded with a
Chroma Fura-2 filter set was used for illumination of
specimens. Images were acquired using Retiga 1300 chilled
digital CCD camera (QImaging). Data processing was
carried out using AQM Advance 6 (Kinetic Imaging Inc)
and MS Excel software. All data are expressed as 340/
380 nm-induced fluorescence of Fura-2 ratio changes
against time (Δ340/380). Each experiment was repeated
at least three times, and data are expressed as means.
For evoking the calcium response, 30 μM MeSADP,
100 μM UTP or 10 μM ADP was used as described by
Sabala et al. [12]. For inhibition of P2Y12,1 0μM AR-
C69931MX was used, and 30 μM MRS 2179 was used for
inhibition of P2Y1 receptors.
Western blot analysis
For the experiments, cells were grown up to 85%
confluency on 100-mm dishes in DMEM supplemented
with 10% NCS. In order to cause serum deprivation, the
medium was replaced by fresh serum-free medium for 96 h.
After this time, cells were washed in PBS, detached with a
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fuged at 3,000 rpm for 5 min and then resuspended in lysis
buffer containing 1% Nonidet P-40, 120 mM NaCl, 50 mM
Tris/HCl, pH 7.5, and freshly added proteinase inhibitors.
Separation of proteins was performed on 12% polyacryl-
amide SDS/PAGE. Proteins were transferred to nitrocellu-
lose membranes (Hybond C, Amersham Pharmacia
Biotech), blocked for 1 h at room temperature with 5%
milk in PBS-T (phosphate-buffered saline pH 7.6/0.005%
Tween 20) and incubated overnight at 4°C with the antisera
against β-actin (Sigma) and P2Y1, P2Y12, and P2Y2 (all
1:2,500, Alomone and Sigma Adrich) diluted in 1% nonfat
milk in PBS-T.
The primary antibody reaction was followed by 2 h incu-
bation with relevant secondary (1:2,500) antibody conjugated
to HRP. Immunocomplexes were detected using the ECL-
enhanced chemiluminescence detection system and mem-
brane exposure to X-ray film. The molecular weight of
proteins was estimated with prestained protein markers
(Fermentas protein ladder). Band intensities were determined
by densitometry analysis in an Ingenious station using
provided programs. Only statistically significant immunoblot
band intensity data are reported.
Statistical analysis
Nonparametric Mann-Whitney U-test was used to discrim-
inate differences between calcium responses. Differences
with P<0.01 were considered highly significant and
marked with two asterisks on the plots, P<0.001 were
marked three asterisks, the lack of statistically significant
difference was marked with a minus sign.
Results
We have previously shown the presence of P2Y1, P2Y2 and
P2Y12 nucleotide receptors in glioma C6 cells using
polymerase chain reaction on reverse-transcribed total
mRNA [11, 12]. We have also shown that the mRNA
expression level, as well as Ca
2+ responses to extracellular
nucleotides, may depend on the presence of serum in the
cell-cultured medium. In cells that have been starved of
serum for 48 h, the expression of the P2Y1 receptor mRNA
decreases and P2Y12 predominates [9, 10]. This change
reflects the lower intensity of Ca
2+ response [9]. Further-
more, we have presented experimental data that the serum-
free chemically defined medium used by other authors [18]
causes similar changes, decreasing the expression of P2Y1
receptor mRNA [10]. These data show that observed
changes are present at the gene expression level.
In the present study, we explored the effects of
prolonged serum deprivaton, up to 96 h, on the expression
of the described receptors and measured changes in their
protein level using Western blot analysis. Figure 1 shows
that upon such treatment, the level of the P2Y1 receptor
protein was very low. Densitometry analysis of blots from
three independent experiments revealed about a 20-fold
decrease in this receptor protein level and a distinct, 3-fold
increase in the P2Y12 receptor.
When the level of P2Y protein receptors in the control
C6 cells, cultivated in the medium supplemented with 10%
new born calf serum, was taken as 100%, the level of P2Y1
receptor protein in the 96-h-deprived serum cells was 6±
2%, and P2Y12 was 306±60% (Fig. 1). Additionally, we
have shown that serum deprivation had no effect either on
P2Y2 mRNA expression [9] or on total receptor protein
level (Fig. 1). Multiple bands observed for P2Y receptors
are probably the effect of protein glycosylation and were
shown to disappear after total receptor deglycosylation
[22]. We investigated such phenomena in glioma C6 cells
and recently showed that preincubation of lysates of cells
Fig. 1 The effect of long-term (96 h) serum deprivation on the
relative expression levels of P2Y1, P2Y2 and P2Y12 receptors. Total
protein isolated from glioma C6 cells was subjected to SDS-PAGE on
12% acrylamide gel and transferred onto nitrocellulose membrane.
Filters were probed with the indicated P2Y antisera. Protein bands
were detected with secondary antisera coupled to HRP by ECL
chemiluminescences. Band intensity was determined by densitometry
analysis. The data represent the means ± SD from three independent
experiments
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2MeSADP-evoked calcium signals. The glioma C6 cells growing in the
medium supplemented with 10% newborn calf serum (control cells) and
those cultivated without serum for 96 h were loaded with Fura-2 and treated
with 30 μM 2MeSADP or 10 μM ADP, as indicated by arrows. a, b, e, f
Experiments performed in the standard buffer containing 2 mM CaCl2. c,
d, g, h Experiments conducted in the absence of extracellular Ca
2+.E a c h
trace represents the mean ratio value of the responses of the indicated
number of cells (n), recorded in five separate experiments. a Black line
Control cells induced by 2MeSADP, n=71; gray line 96-h starved cells,
n=79. b Ca
2+ responses in 96-h serum-deprived cells induced by
2MeSADP, n=79, divided into groups according to the extent of response
(light gray: cells with strong response, medium gray: cells with medium
response, dark gray: cells with weak response). Black line Mean ratio
value. c Control cells induced by 2MeSADP, n=51. d 96-h starved cells
induced by 2MeSADP, n=49. e Black line Control cells induced by ADP,
n=51;gray line 96-h starved cells, n=134. f Ca
2+ responses in 96-h serum-
deprived cells induced by ADP, n=134, divided into groups according to
the extent of response (light gray cells with strong response, medium gray
cellswith mediumresponse, dark gray cells with weak response). Black line
Mean ratio value. g Control cells induced by ADP, n=97. h 96-h starved
cells induced by ADP, n=235. ***P<0.001
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detected by P2Y antibodies [23].
Since under long-term serum starvation the P2Y12
receptor expression strongly predominates, one could
suppose that this receptor might be primarily involved in
ADP- or 2MeSADP-evoked signal transduction. Slegers
group [18] suggested the existence of an alternative, IP3-
independent, calcium influx pathway caused by P2Y12
receptor activation [19, 20].
The fact that in long-term serum-deprived C6 glioma
cells the P2Y12 receptor is massively expressed and P2Y1
strongly diminished provides a good model system to study
functional properties of both receptors. Therefore, in our
subsequent experiments, Ca
2+ responses to nucleotides in
the control cells were compared to those in the cells
growing 96 h in the medium without serum.
Figure 2 shows the effect of 30 μM 2MeSADP (Fig. 2a–
d) and 10 μM ADP (Fig. 2e–h) on Ca
2+ response in the
control, nonstarved cells, and in the 96-h serum-starved
cells. Figure 2a, b, e, f shows cells studied in the
extracellular medium containing 2 mM CaCl2,w h i l e
Fig. 2c, d, g, h shows calcium transients in cells tested in
the medium containing 500 μM EGTA. Statistical analysis
(mean value ± SD from at least three separate experiments
for the indicated number of cells; data were standardized to
obtain stationary calcium levels equal 1 arbitrary unit, AU)
Fig. 3 The effect of AR-C69931MX, the P2Y12 receptor antagonist,
on Ca
2+ signals evoked by 30 μM 2MeSADP (a, b), 10 μM ADP
(c, d), and 100 μM UTP (e, f). Black lines represent mean ratio values
of Ca
2+ responses of cells untreated with P2Y12 antagonist. a, c, e
Nonstarved cells, respectively, n=71, n=51, n=73. b, d 96-h serum-
starved cells, respectively, n=79, n=134. Gray lines in the same
panels represent mean ratio value of Ca
2+ responses of cells pre-
treated for 3 min with 10 μM AR-C69931MX (a, n = 95; b, n=80;
c, n=19 ; d, n=175; e, n=79) and then, while still in its presence,
stimulated by agonist, as indicated by arrows. f 100 μM UTP-evoked
Ca
2+ signals in the control cells (n=73, black line); and 96-h serum-
starved cells, (n=120, gray line). Each trace represents mean ratio
value from five experiments. ***P<0.001. Statistically insignificant
differences are indicated with a minus sign
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2+ peak
evoked by 2MeSADP (Fig. 2a) and ADP (Fig. 2e) were
1.50±0.15 AU for 2MeSADP (n=71) and 1.47±0.37 AU
for ADP (n=51), whereas the values in serum-starved cells
were 1.19±0.21 AU for 2MeSADP (n=79) and 1.17±
0.25 AU for ADP (n=134). The difference was statistically
significant with P<0.001.
The calcium signal strength thus fell to ~0.2 AU from
~0.5 AU indicating 60% inhibition of the signal. The initial
calcium transient was associated with the depletion of
intracellular stores (the first phase of the calcium response),
followed by sustained elevation of Ca
2+ (the second phase
of the calcium response), which was a result of a
subsequent influx of extracellular Ca
2+ to the cells.
It is worth adding that Ca
2+ responses are often analyzed
only in cells that respond to agonists. We have previously
shown that 70–95% of glioma C6 cells, growing in the
medium supplemented with serum responded to extracellular
nucleotides [12]. Similarly, of the control cells presented in
Fig. 2a and e, 80% responded to agonist. In contrast, among
serum-deprived cells, only 8.8% (7 out of 79) responded to
2MeSADP, and 16.4% responded to ADP (22 out of 134).
Therefore, the traces shown in Fig. 2aa n der e p r e s e n tm e a n
values of all individual cell responses, including those
responding and those not responding to the agonist.
Figure 2b and f shows Ca
2+ responses in 96-h serum-
deprived cells, divided into groups according to the extent
of the response. It is shown that in the cells with the highest
response, a rapid rise in intracellular Ca
2+ level associated
with the depletion of the ER stores is emphasized (the first
phase), whereas the second phase is diminished. Figure 2c,
d, g and h shows Ca
2+ responses in the absence of
extracellular Ca
2+. It is shown that addition of agonist
resulted only in the initial transient rise in intracellular Ca
2+
concentration, which declined to the basal level (the first
phase of the calcium response) indicating that this phase of
the cytosolic Ca
2+ increase was indeed caused by mobili-
zation of intracellular Ca
2+ stores. The mean values of Ca
2+
elevation in control cells were 1.30±0.17 AU (n=51,
Fig. 2c) for 2MeSADP and 1.25±0.56 AU (n=97,
Fig. 2g) for ADP; the values in serum-starved cells were
1.05±0.13 AU (n=49, Fig. 2d) for 2MeSADP and 1.03±
0.27 AU (n=235, Fig. 2h) for ADP. Among serum-
deprived cells, 10% (5 out of 49) responded to 2MeSADP
and 7% (17 out of 235) to ADP.
Thus, the very low expression of the P2Y1 receptor in
long-term serum-deprived cells strictly corresponds to the
low intensity of the functional effects. When, in serum-
starved cells, the P2Y1 receptor protein level decreases to
6% of that in the control cells, this change is reflected by
approximately 10% of the cells strongly responding to
2MeSADP or ADP. Since in serum-starved cells the
expression of P2Y12 receptor protein distinctly increases,
low calcium responses reflect stimulation of P2Y1 and not
of P2Y12 receptor. Nevertheless, the average calcium signal
reduction is much weaker than can be expected from 94%
reduction of P2Y1 receptor protein level.
To check the possibility that P2Y12 may still play a role
in contributing to the agonist-induced Ca
2+ response, the
extent of inhibition of this response by the P2Y12 selective
antagonist AR-C69931MX (10 μM) was determined.
Figure 3 shows that both in the control, nonstarved
(Fig. 3a, c) and in the serum-deprived (Fig. 3b, d) cells,
AR-C69931MX reduced the strength of the calcium
response (measured as the signal integral) to 2MeSADP
by 42.3% (Fig. 3a) and 69.8% (Fig. 3b), respectively, and
to ADP by 31.9% (Fig. 3c) and 57.3% (Fig. 3d). In both
cases the difference was statistically significant with P<
0.005. It is important to notice that, as shown in Fig. 3a and
c, the observed difference in calcium signal integral caused
by AR-C69931MX affected the second phase of calcium
response. Since the plots presented in Fig. 3 show the
overlay, we can not precisely state whether or not the fall of
the initial peak in Fig. 3a is the result of the strong second-
phase reduction.
In order to demonstrate that AR-C69931MX has no
effect upon other P2Y receptors, Ca
2+ responses were
evoked by UTP (100 μM), an agonist of the P2Y2 receptor.
In these cases, there was no statistically significant change
in the peak response either in the presence or absence of
this antagonist (Fig. 3e). It is worth adding that MRS2179,
the P2Y1 receptor antagonist, led to a 96% reduction in
calcium response induced by ADP [10, 11], or 75%
reduction if induced by 2MeSADP (data not shown).
Figure 3f also shows that the UTP-generated Ca
2+ response
is diminished in the 96-h serum-starved cells. In the control
cells, the initial peak of Ca
2+ elevation was 2.50±0.23 AU
(n=73), whereas in the serum-deprived cells it was 1.58±
0.16 AU (n=120). The difference was statistically signif-
icant with P<0.001. Thus, 96-h, prolonged cell cultivation
in the medium without serum blocked the effect of UTP by
approximately 47.4%. On the other hand, serum-depriva-
tion did not decrease the expression level of P2Y2 receptor
protein (Fig. 1).
Figure 4a shows two phases of calcium response in
glioma C6 cells. The signal was evoked by UTP in the Ca
2+-
free medium. Under such conditions, the rise in Ca2þ ½  i was
the effect of depletion of intracellular stores (ER). When the
transient rise in calcium returned to the basal level, a
standard, calcium-containing buffer was added. The addition
of Ca
2+ to the extracellular medium generated a high
elevation in the cytosolic Ca
2+ concentration. These data
demonstrate that the Ca
2+ entry is solely activated by the
depletion of the ER Ca
2+ store.
However, when we compared UTP-induced Ca
2+
responses in the control (1.95±0.27 AU, n=95) and
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2+-
free medium, there was a visible difference in the response
of both groups. The response to UTP in 96-h serum-
deprived cells was much lower, and the difference was
statistically significant with P<0.001. On the other hand,
after exchanging that medium for one containing Ca
2+, the
strong and rapid elevation of the cytosolic Ca
2+ level was
the same in both control (1.92±0.28 AU, n=95) and serum-
deprived (1.83±0.24 AU, n=83) cells (Fig. 4a); the
difference was statistically insignificant.
Please note that the data suggested that the different
response to UTP in Ca
2+-free medium observed in the two
groups of cells (see also Fig. 3d) not only depended on the
expression of physiologically active receptors (which in this
case was on the same level in both starved and nonstarved
groups of cells) but also on the amount of Ca
2+ present in
the intracellular store. Tocheck this assumption, 96-h serum-
starved cells were placed in a buffer without Ca
2+ for about
8 min, and then the buffer was changed for that containing
2 mM CaCl2. This change resulted in a rapid increase in
[Ca
2+]i caused by extracellular Ca
2+ influx (1.28±0.14 AU,
n=114) (Fig. 4b). Thus, prolonged, 96-h serum deprivation
constitutes inhospitable conditions, manifested not only in
the decrease in the P2Y1 receptor expression but also in a
partial, autonomous depletion of ER stores from Ca
2+.
Nonstarved cells did not respond by increasing [Ca
2+]i
when there was an exchange from calcium-free medium
with that containing 2 mM CaCl2 (Fig. 4b, n=36).
Therefore, in the long-term serum-starved glioma C6
cells tested in Ca
2+-free buffer, there was a very small, but
statistically significant (P< 0 . 0 0 1 )i n c r e a s ei n Ca2þ ½  i (0.31±
0.11 AU, n=111, Fig. 4c) induced by 2MeSADP. It was
caused by both the low expression of the P2Y1 receptor
protein level and by a partial depletion of ER stores from
Ca
2+ (Figs. 2da n d4c). The change in the extracellular
medium for the buffer containing Ca
2+ caused Ca
2+ influx to
the cells (Fig. 4c). The influx after 96 h of serum starvation
was even stronger (1.93±0.31 AU, n=107) than in control
cells (1.43±0.24 AU, n=111); the difference was statistically
significant with P<0.01. It is the depletion of ER stores that
gives a signaltovoltage-independent Ca
2+ channels and Ca
2+
entry across plasma membranes, according to the mecha-
nism of the capacitative Ca
2+ entry.
In subsequent experiments, the role of P2Y12 on the
capacitative Ca
2+ entry was examined in the nonstarved
cells. In such experiments the cells were incubated in the
medium without Ca
2+ (Fig. 5a). After addition of ADP, the
first phase of calcium response was observed. Thereafter
the medium was replaced by standard buffer containing
2 mM CaCl2 (with no agonist).
To distinguish if the P2Y12 receptor plays an active role
in the calcium signal formation or if it only modulates the
result of P2Y1 receptor activity, we used AR-C69931MX in
two separate experimental setups. In the first experiment,
P2Y12 receptor competitive antagonist was used before
addition of agonist to inhibit both hypothetical P2Y12 direct
calcium signalling as well as regulation of P2Y1 activity by
P2Y12 receptor. In the second experiment, the use of
antagonist well after agonist addition but before medium
Fig. 4 a–c The effect of intracellular store depletion evoked by UTP,
2MeSADP, or by incubation in the calcium-free buffer on Ca
2+ influx
in glioma C6 cells. a 100 μM UTP was added to the control cells
(black line, n=73), or to 96-h serum-starved cells (gray line, n=120),
placed in a buffer without Ca
2+ and with 500 μM EGTA. Next, 5 min
after the addition of UTP, the buffer was changed for the buffer
containing 2 mM CaCl2 (Ca
2+). b The control cells (black line, n=30)
and 96-h serum-starved cells (gray line, n=114) were placed in a
buffer without Ca
2+ and with 500 μM EGTA, and after 8 min
incubation in the Ca
2+-free buffer, new buffer containing 2 mM CaCl2
(Ca
2+) was added. c 30 μM 2MeSADP was added to the control cells
(black line, n=78) or to 96-h serum-starved cells (gray line, n=92)
placed in a buffer without Ca
2+ and with 500 μM EGTA; 5 min after
the addition of 2MeSADP, the buffer was changed for the buffer
containing 2 mM CaCl2 (Ca
2+). Each trace in a, b, and c represents the
mean value for the indicated number of cells tested in three to five
experiments. *** P<0.001, **P<0.01. Statistically insignificant
differences are marked with a minus sign
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regulatory functions of P2Y12 receptor but not its ability to
directly form the calcium signal.
As has been shown, AR-C69931MX has an inhibitory
effect on the second phase of Ca
2+ response, however this
effect does not depend on the moment of the antagonist
addition (cells treated with AR-C69931MX before ADP
addition: 1.43±0.44 AU, n=12; cells treated with AR-
C69931MX after ADP addition: 1.55±0.42 AU, n=18; the
difference was not statistically significant) (Fig. 5b).
Figure 5b also shows that AR-C69931MX has no statisti-
cally significant effect on the first phase of the calcium
response. The same results were observed when 2MeSADP
was used as an agonist (data not shown).
Discussion
It is now well-documented that in the Gq-dependent
signalling initiated by ADP or 2MeSADP, the P2Y1
receptor stimulation triggers PLCβ activation and Ca2þ ½  i
increase [9–17]. On the other hand, the same agonists, via
the P2Y12 receptor, activate the Gi pathway and inhibit
adenylate cyclase in various animal cells [11, 12, 18, 24,
25]. The cross-talk between those two receptors is
extremely complex [9, 26]. In human platelets, Sage et al.
[27] and Fox et al. [28] suggested that P2Y12 may enhance
P2Y1-induced cytosolic Ca
2+ rise, whereas Daniel et al.
[29] presented evidence that this receptor is not involved in
such response. Hardy et al. [30] have explained this
conflicting evidence as the different conditions used during
platelets preparation. Similarly in glioma C6 cells, there is
conflicting evidence regarding the role of P2Y1 in ADP-
mediated calcium response that can also be explained by
the differences in the culture conditions [10]. Presence or
absence of serum in the culture medium provides con-
clusions on functional activity [9–11] or inactivity [18]o f
this receptor.
Hardy et al. [30], as well as Sage et al. [27], suggested
the modulatory role of P2Y12, positively regulating P2Y1-
induced Ca
2+ response. It has been suggested that this
potentiation is mediated by P2Y12-induced inhibition of
adenylate cyclase and activation of phosphatidylinositol 3-
kinase (PI3-K), whereas the effect of P2Y1 on PI3-K is
inhibitory [30]. Our previous study concerning cross-talk
between nucleotide receptor-induced signalling pathways in
glioma C6 cells also revealed P2Y1 inhibitory and P2Y12
stimulatory effects on PI3-K signalling [9, 10]. Thus, since
stimulation of the P2Y12 receptor in glioma C6 inhibits
adenylate cyclase [11, 12] and stimulates PI3-K [9, 10], its
modulatory effect on the P2Y1-induced Ca
2+ responses in
this cell line may occur via a similar mechanism to the one
suggested in platelets [30]. It has been proposed that in this
process the cAMP-dependent pathway has a stimulatory
effect on PM calcium pumps, thereby limiting the strength
of the calcium response. The P2Y12 receptor reduced this
effect by inhibition of adenylate cyclase activity. Hardy et
al. [30] suggested that PI3-K, activated by the P2Y12
receptor stimulation, may also activate PLCγ, leading to
the rise in PIP3 and enhancement of the calcium signal. It
has been reported that receptors coupled to PI3-K may
activate PLCγ indirectly in the absence of PLCγ-tyrosine
phosphorylation [31, 32].
Our study confirms the conclusions of Hardy et al. [30]
concerning the positive regulatory role of P2Y12 potentiat-
ing the P2Y1-induced rise in intracellular Ca
2+ level. We
have shown here that, in glioma C6, the calcium response
to ADP or its analogue 2MeSADP is directly dependent
Fig. 5 a, b The effect of AR-C69931MX, the P2Y12 receptor
antagonist, on the first and second phase of calcium response in cells
grown in the presence of serum. a Cells in Ca
2+-free buffer were
stimulated by 10 μM ADP (arrow). Two cell groups were studied: the first
experimental group was treated with 10 μM AR-C69931MX for 3 min
before ADP addition and release of calcium from the ER (light gray line,
ARC - ADP), while the second experimental group was treated for 3 min
with 10 μM AR-C69931MX just after the end of calcium transient caused
by ADP-induced release from the ER (dark gray line, ADP - ARC). The
control cell group was induced with ADP, without use of AR-C69931MX
(black line, Ctrl). Then, in all cell groups, the medium was exchanged with
fresh medium containing 2 mM CaCl2 (arrow). b Strength of two phases
of calcium response. Colour of bars as described above. Difference
between bars marked with a minus sign is statistically insignificant
228 Purinergic Signalling (2007) 3:221–230upon activation of the P2Y1 receptor. The modulatory effect
of P2Y12 receptor on intracellular free calcium level seems
to be a result of the PM calcium pump inhibition [26]. The
pump activity is enhanced by cAMP. The constant
activation of P2Y12 receptor lowers the level of cAMP
and inhibits the PMCA pump. Thus, inhibition of this
receptor activity may enhance the pump efficiency and
lower the calcium signal as shown in the present study
when we observed decreased calcium influx under the
influence of the P2Y12 competitive antagonist AR-
C69931MX (Fig. 5). A similar phenomenon of calcium-
removal inhibition was described in platelets, where the
adenylate cyclase inhibitor SQ22536 reduced the strength
of calcium signal by approximately 50% [26].
Thus, the suggestion that Ca
2+ influx in this cell line
may involve a channel, activated directly or indirectly by
protein Gβγ subunits after the P2Y12 receptor stimulation
(see figures in [19, 20]), seems to be doubtful. If such a
channel were to exist it should be opened by an agonist
when P2Y12 antagonist is added after addition of the
agonist and remain closed if P2Y12 antagonist is added
before this agonist (Fig. 5). Since we did not observe such a
difference in the calcium signal strength we may exclude
the existence of a P2Y12-dependent calcium channel in
glioma C6 cells. Even if there is some evidence that the
stimulation of P2Y receptors may affect N-type Ca
2+currents
[33], glioma C6 cells belong to the type of nonexcitable cells
and do not possess voltage-dependent Ca
2+ channels [3].
In conclusion, the present study shows that Ca
2+ influx
in these cells occurs exclusively via the mechanism of
capacitative calcium entry. Thus any activation of calcium-
dependent signalling pathways resulting from the presence
of extracellular ADP must be the result of P2Y1-P2Y12
cross-talk, not solely P2Y12 receptor activity. Nevertheless,
the P2Y12 modulatory effect on glioma C6 calcium
signalling seems to be very important.
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